Ascendis Pharma Endocrinology Division A/S
USPTO Trademark & Patent Filings
Trademark applications and grants for Ascendis Pharma Endocrinology Division A/s. Ascendis Pharma Endocrinology Division A/s has 14 trademark applications. The latest application filed is for "KNOWHYPOPARA"
- Company Aliases
- Ascendis Pharma Endocrinology Division A/S
- Ascendis Pharma Endocrinology Division A/S - Hellerup DK
| State Incorporated | DENMARK |
| Entity Type | aktieselskab (a/s) |
| Address | Tuborg Boulevard 12 Hellerup DENMARK 2900 |
Trademarks Patents
| Patent Application | Date |
|---|---|
| LONG-ACTING GROWTH HORMONE DOSAGE FORMS WITH SUPERIOR EFFICACY TO DAILY SOMATROPIN 20220088147 - 17/310993 SPROGOE; Kennett | 2022-03-24 |
| PEGylated Recombinant Human Growth Hormone Compounds 20210220442 - 17/215991 Rau; Harald ; et al. | 2021-07-22 |
| Novel Polymeric hGH Prodrugs 20200390864 - 17/006589 Kurpiers; Thomas ; et al. | 2020-12-17 |
| Dry Growth Hormone Composition Transiently Linked to a Polymer Carrier 20200261544 - Rasmussen; Grethe Norskov ; et al. | 2020-08-20 |
| PEGylated Recombinant Human Growth Hormone Compounds 20190192634 - 16/146253 Rau; Harald ; et al. | 2019-06-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 